Warsaw, Poland Clinical Trials

A listing of Warsaw, Poland clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 563 clinical trials
Featured trial
Retrospective study examining the differences in vocalizations of babies and toddlers with Rett compared to same age peers

Retrospective study examining the differences in vocalizations of babies and toddlers with Rett compared to same age peers: We are looking to recruit children and their parent(s) to participate in a study examining the early speech development of infants and toddlers later diagnosed with Rett syndrome, compared to girls their …

Online studies
Accepts healthy volunteers
The University of Tennessee Health Science Center
(online study) Contact site
  • 20 views
  • 30 Jun, 2022
  • 1 location
  • Online study
Featured trial
Parkinson Progression Marker Initiative Online (PPMI Online)

Parkinson Progression Marker Initiative Online (PPMI online) is part of the broader Parkinson’s Progression Marker Initiative aimed at better understanding who gets Parkinson’s disease and why. PPMI online is a study collecting participant reported demographic and health information online from people with and without Parkinson’s disease. Once in the study, …

Online studies
Accepts healthy volunteers
UCSF Movement Disorders and Neuromodulation Center (MDNC)
(online study) Contact site
  • 94 views
  • 30 Mar, 2022
  • 1 location
  • Online study
Featured trial
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Welcome to TogetherA study for memory loss If you are concerned about changes to your memory, joining the Together clinical study might be a suitable option for you. To qualify for this study, you must:·         Be between 50 and 80 years old·         Have mild memory problems or early Alzheimer’s disease·         Meet some additional study criteria The …

cognitive assessment
alzheimer's disease
mental state examination
positron emission tomography
dementia
Ah0003 40603
 (109.3 away) Contact site
  • 49 views
  • 30 Jun, 2022
  • +85 other locations
Featured trial
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

www.MyelofibrosisResearch.com Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tissues in the body. MF disturbs the body's normal production of blood cells, causing extensive scarring in the bone marrow. This leads to severe anemia, weakness, fatigue, and an enlarged spleen. The purpose of this study is to assess …

MTZ Clinical Research SP. zoo /ID# 221759
 (2.2 away) Contact site
  • 817 views
  • 29 Jun, 2022
  • +225 other locations
Featured trial
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication. 

early parkinson's
bradykinesia
SPECT Scan
tremor
dopamine
Samodzielny Publiczny Szpital Kliniczny im. prof. Orlowskiego; Klinika Neurologii i Epileptologii
 (1.1 away) Contact site
  • 151 views
  • 01 Jul, 2022
  • +102 other locations
Featured trial
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

This study consists of 2 parts. Part 1 of the study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to placebo in subjects with early Parkinson's Disease who are not receiving dopaminergic therapy. Part 2 is an optional long term extension study for …

early parkinson's
SINGUA Sp. Z o.o.
 (2.2 away) Contact site
  • 5 views
  • 22 Jun, 2022
  • +75 other locations
Featured trial
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in participants with dementia of the Alzheimer's type.

dementia
agitation
Centrum Medyczne Neuroprotect
 (4.0 away) Contact site
  • 0 views
  • 01 Jul, 2022
  • +63 other locations
Featured trial
A Phase 2 Study of INCMGA00012 (PD-1 Inhibitor) in Participants With Selected Solid Tumors (POD1UM-203)

The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with advanced solid tumors where the efficacy of PD-1 inhibitors has previously been established.  

solid tumor
solid tumors
Centrum Onkologii- Instytut Im. Marii Sklodowskiej-Curie
 (6.0 away) Contact site
  • 84 views
  • 10 May, 2022
  • +52 other locations
Featured trial
A Phase 4, Randomized, Open-label, Multicenter Efficacy and Safety Study of Standard Dose of Radium-223 Dichloride vs. Standard Doses of Novel Anti-hormonal Therapy (NAH) in Patients With Bone Dominant Metastatic Castration Resistant Prostate Cancer (mCRPC) Progressing on/After One Line of NAH

Researchers in this study want to compare how well drug radium-223 dichloride (Xofigo) and new (novel) anti-hormonal (NAH) therapy work in participants with prostate gland cancer which has spread to the bone and progressed on or after one line of NAH therapy. Meanwhile researchers want to compare the safety of …

Grochowski Hospital
 (2.9 away) Contact site
  • 13 views
  • 08 Feb, 2022
  • +19 other locations
Featured trial
A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy (KRYSTAL-10)

Study 849-010 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab versus chemotherapy in the second-line treatment setting in patients with CRC with KRAS G12C mutation.

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Klinika Onkologii i Radioterapii
 (1.5 away) Contact site
  • 62 views
  • 27 Apr, 2022
  • +134 other locations